Post-imprinting modification of molecularly imprinted polymer for proteins detection: A review.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
31 Dec 2023
Historique:
received: 17 08 2023
revised: 17 09 2023
accepted: 25 09 2023
medline: 29 11 2023
pubmed: 29 9 2023
entrez: 28 9 2023
Statut: ppublish

Résumé

Inspired by protein post-translational modification (PTM), post-imprinting modification (PIM) has been proposed and developed to prepare novel molecularly imprinted polymers (MIPs), which are similar to functionalized biosynthetic proteins. The PIM involves site-directed modifications in the imprinted cavity of the MIP, such as introducing high-affinity binding sites and introducing fluorescent signal molecules. This modification makes the MIP further functionalized and improves the shortcomings of general molecular imprinting, such as single function, low selectivity, low sensitivity, and inability to fully restore the complex function of natural antibodies. This paper describes the characteristics of PIM strategies, reviews the latest research progress in the recognition and detection of protein biomarkers such as lysozyme, prostate-specific antigen, alpha-fetoprotein, human serum albumin, and peptides, and further discusses the importance, main challenges, and development prospects of PIM. The PIM technology has the potential to develop a new generation of biomimetic recognition materials beyond natural antibodies. It can be used in bioanalysis and other multitudinous fields for its unique features in molecule recognition.

Identifiants

pubmed: 37769758
pii: S0141-8130(23)04001-1
doi: 10.1016/j.ijbiomac.2023.127104
pii:
doi:

Substances chimiques

Molecularly Imprinted Polymers 0
Polymers 0
Antibodies 0
Prostate-Specific Antigen EC 3.4.21.77

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

127104

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yi Yang (Y)

Faculty of Science, Kunming University of Science and Technology, Kunming 650500, China.

Xiaomei He (X)

Faculty of Science, Kunming University of Science and Technology, Kunming 650500, China.

Shufang Xu (S)

Faculty of Science, Kunming University of Science and Technology, Kunming 650500, China.

Dan Wang (D)

Faculty of Science, Kunming University of Science and Technology, Kunming 650500, China.

Zhimin Liu (Z)

Faculty of Science, Kunming University of Science and Technology, Kunming 650500, China. Electronic address: lab_chem@126.com.

Zhigang Xu (Z)

Faculty of Science, Kunming University of Science and Technology, Kunming 650500, China. Electronic address: xuzgkmust@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH